The quantification with FDG as seen by a physician

Nuclear Medicine and Biology

Volumn 40, Issue 6, 2013, Pages 720-730

  Galli, Guido ^a   Indovina, Luca ^a   Calcagni, Maria Lucia ^a   Mansi, Luigi ^b   Giordano, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Compartmental model; FDG; Influx constant; Metabolic rate; MRglu; Simplified methods

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

AUTORADIOGRAPHY; BLOMQVIST METHOD; BODY SURFACE; BRAIN TUMOR; CLINICAL PRACTICE; COMPARTMENT MODEL; CONCENTRATION (PARAMETERS); CONSTANTS AND COEFFICIENTS; GLUCOSE METABOLISM; HUMAN; HUNTER METHOD; INTERMETHOD COMPARISON; LEAN BODY WEIGHT; LUNG TUMOR; MATHEMATICAL ANALYSIS; MATHEMATICAL PARAMETERS; MATHEMATICAL VARIABLE; NONHUMAN; NONLINEAR REGRESSION ANALYSIS; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; RUTLAND PATLAK METHOD; SADATO METHOD;

EID: 84880983807     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.06.009     Document Type: Review

References (23)

1. Spence A.M., Muzi M., Mankoff D.A., O'Sullivan S.F., Link J.M., Lewellen T.K., et al. 18F-FDG PET of Gliomas at Delayed Intervals: Improved Distinction Between Tumor and Normal Gray Matter. J Nucl Med 2004, 45:1653-1659.
2. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977, 28:897-916.
3. Feng D., Ho D., Chen K., Wu L.C., Wang J.K., Liu R.S., et al. An evaluation of the algorithms for determining local cerebral metabolic rates of glucose using Positron Emission Tomography dynamic data. IEEE Trans Med Imaging 1995, 14:697-710.
4. Wienhard K. The FDG model and its application in clinical PET studies. J Neural Transm 1992, 37(Suppl.):39-52.
5. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-Fluoro-2-Deoxy-D-Glucose: validation of method. Ann Neurol 1979, 6:371-388.
6. Sokoloff L. The deoxyglucose method: theory and practice. Eur Neurol 1981, 20:137-145.
7. Rhodes C.G., Wise R.J., Gibbs J.M., Frackowiak R.S., Hatazawa J., Palmer A.J., et al. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 1983, 14:614-626.
8. Hutchins G.D., Holden J.E., Koeppe R.A., Halama J.R., Gatley S.J., Nickles R.J. Alternative approaches to single scan estimation of cerebral glucose metabolic rate using glucose analogues, with particular application to ischemia. J Cereb Blood Flow Metab 1984, 4:35-40.
9. Hunter G.J., Hamberg L.M., Alpert N.M., Choi N.C., Fischman A.J. Simplified measurement of deoxyglucose utilization rate. J Nucl Med 1996, 37:950-955.
10. Wakita K., Imahori Y., Ido T., Fujii R., Horii H., Shimizu M., et al. Simplification for measuring input function of FDG Pet: investigation of 1-point blood sampling method. J Nucl Med 2000, 41:1484-1490.
11. Sadato N., Tsuchida T., Nakaumra S., Waki A., Uematsu H., Takahashi N., et al. Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours. Eur J Nucl Med 1998, 25:559-564.
12. Zasadny K.R., Wahl R.L. Standardized Uptake Values of normal tissues at PET with 2-[Fluorine-18]-Fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction. Radiology 1993, 189:847-850.
13. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983, 3:1-7.
14. Patlak C.S., Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time-uptake data: generalization. J Cereb Blood Flow Metab 1985, 5:584-590.
15. 131I-hippuran renograms. Br J Radiol 1979, 52:134-137.
16. Rutland M.D. Mean transit times without deconvolution. Nucl Med Commun 1981, 2(6):337-344.
17. Peters A.M. Graphical analysis of dynamic data: the Patlak-Rutland plot. Nucl Med Commun 1994, 15:669-672.
18. Lucignani G., Schmidt K.C., Moresco R.M., Striano G., Colombo F., Sokoloff L., et al. Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure. J Nucl Med 1993, 34:360-369.
19. Blomqvist G. On the construction of functional maps in positron emission tomography. J Cereb Blood Flow Metab 1984, 4:629-632.
20. Blomqvist G., Stone-Elander S., Halldin C., Roland P.E., Widén L., Lindqvist M., et al. Positron emission tomographic measurements of cerebral glucose utilization using [11-C]D-glucose. J Cereb Blood Flow Metab 1990, 10:467-483.
21. 11C-deoxyglucose. J Cereb Blood Flow Metab 1985, 5:179-192.
22. Spence A.M., Muzi M., Graham M.M., O'Sullivan F., Krohn K.A., Link J.M., et al. Glucose metabolism in human gliomas measured quantitatively with PET, [C-11] glucose and FDG: analysis of FDG lumped constant. J Nucl Med 1998, 39:440-448.
23. Hasselbalch S.G., Madsen P.L., Knudsen G.M., Holm S., Paulson O.B. Calculation of FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans. J Cereb Blood Flow Metab 1998, 18:154-160.